Table of Contents Understanding Oral GLP-1 Therapy Advances in Dosing and Administration Impact on Early Treatment Decisions Implications for Obesity and Metabolic Care Conclusion FAQs Understanding Oral GLP-1 Therapy Oral GLP-1 therapy refers to medications that mimic the glucagon-like peptide-1 hormone, helping regulate blood sugar and appetite
Addressing Common Absorption Barriers Things like stomach problems, some meds, and getting older can make it hard to absorb vitamin B12
A review published by the National Institutes of Health highlights how GLP-1induced gastric slowing is most pronounced during early treatment phases
GLP-1 receptor agonists mimic a naturally occurring gut hormone called glucagon-like peptide-1 (GLP-1), which slows how quickly food moves from your stomach into your small intestine
These secondary effects, such as gut microbiome dysbiosis, reduced diversity, and barrier compromise, may offset the anti-inflammatory effects of these medications